rs761966457
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_014467.3(SRPX2):c.1238G>A(p.Arg413His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000339 in 1,209,214 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 24 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_014467.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SRPX2 | NM_014467.3 | c.1238G>A | p.Arg413His | missense_variant | 11/11 | ENST00000373004.5 | NP_055282.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SRPX2 | ENST00000373004.5 | c.1238G>A | p.Arg413His | missense_variant | 11/11 | 1 | NM_014467.3 | ENSP00000362095 | P1 | |
SRPX2 | ENST00000640282.1 | c.162G>A | p.Ser54= | synonymous_variant | 3/3 | 5 | ENSP00000491188 | |||
SRPX2 | ENST00000638920.1 | n.1241G>A | non_coding_transcript_exon_variant | 10/10 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000180 AC: 2AN: 111003Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33227
GnomAD3 exomes AF: 0.0000874 AC: 16AN: 182996Hom.: 0 AF XY: 0.000148 AC XY: 10AN XY: 67558
GnomAD4 exome AF: 0.0000355 AC: 39AN: 1098211Hom.: 0 Cov.: 31 AF XY: 0.0000660 AC XY: 24AN XY: 363569
GnomAD4 genome AF: 0.0000180 AC: 2AN: 111003Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33227
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 20, 2022 | The c.1238G>A (p.R413H) alteration is located in exon 11 (coding exon 10) of the SRPX2 gene. This alteration results from a G to A substitution at nucleotide position 1238, causing the arginine (R) at amino acid position 413 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 01, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SRPX2 protein function. ClinVar contains an entry for this variant (Variation ID: 566880). This variant has not been reported in the literature in individuals affected with SRPX2-related conditions. This variant is present in population databases (rs761966457, gnomAD 0.07%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 413 of the SRPX2 protein (p.Arg413His). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at